Climb Bio Inc (CLYM) earnings · rev $8.1M
These earnings events as JSON? API free 100/dayClimb Bio Inc (CLYM) is a biotechnology company listed on US.
This CLYM earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported CLYM revenue for 2024-12-31 was $8.1M. Net income was -$73.9M. Revenue was up 76.0% from 2023-12-31 to 2024-12-31. CLYM currently screens at market cap $85.8M.
When the next CLYM 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 76.0% from 2023-12-31 to 2024-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full CLYM research stays on the stock page; the tape stays on the quote page.
CLYM earnings FAQ
What are CLYM's latest revenue and net income?
Latest cached Climb Bio Inc (CLYM) revenue for Dec 31, 2024 was $8.1M. Net income was -$73.9M. Statements: https://lician.com/financials/clym
What is CLYM's latest diluted EPS?
Latest cached Climb Bio Inc (CLYM) diluted EPS for Dec 31, 2024 was -$1.53.
What period does the latest CLYM earnings print cover?
The latest cached Climb Bio Inc (CLYM) earnings print covers Dec 31, 2024. The prior cached period on this page is Dec 31, 2023.
How did CLYM revenue change from the prior cached period?
Cached Climb Bio Inc (CLYM) revenue was up 76.0% from $4.6M (Dec 31, 2023) to $8.1M (Dec 31, 2024). Statements: https://lician.com/financials/clym
Where are CLYM earnings listed?
Cached earnings facts for Climb Bio Inc (CLYM) are listed at https://lician.com/earnings/clym. Statements: https://lician.com/financials/clym
Not investment advice.